Hot Features
プレミアム
Sernova Biotherapeutics Inc (PK) (SEOVF)
USOTC
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Ms. Tanya N. LewisIndependent Director & Observer | 426.48k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.56M | 37.63% |
| 2026-05-22 | Mr. David PatersonIndependent Director | 454.23k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.73M | 35.53% |
| 2026-05-22 | Dr. Stephen SanghaIndependent Director | 260.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 2.54M | 11.40% |
| 2026-05-22 | Dr. Bernd MuehlenwegIndependent Director | 433.42k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.74M | 33.30% |
| 2026-05-22 | Mr. John L. BrooksIndependent Chairman | 588.91k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.73M | 51.45% |
| 2026-04-16 | Dr. Stephen SanghaIndependent Director | 26.67M | 2.92M | 買い | 0.11 | 49.70M | 115.76% |
| 2026-04-14 | Dr. Stephen SanghaIndependent Director | 10.00M | 1.09M | 買い | 0.11 | 23.04M | 76.70% |
| 2026-04-14 | Mr. Jonathan M. N. RigbyPresident, CEO & Director | 229.88k | 31.74k | 買い | 0.14 | 229.88k | - |
| 2026-04-14 | Mr. James T. ParsonsCFO | 229.88k | 31.74k | 買い | 0.14 | 614.61k | 59.75% |
| 2026-03-03 | Mr. James T. ParsonsCFO | -100.00k | 0.00 | Other Derivative Disposition | - | 0.00 | -100.00% |
| 2026-03-03 | Dr. Stephen SanghaIndependent Director | -880.00k | 0.00 | Other Derivative Disposition | - | 16.00M | -5.21% |
| 2026-02-24 | Mr. John L. BrooksIndependent Chairman | 1.14M | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.14M | - |
| 2026-02-24 | Mr. James T. ParsonsCFO | 2.25M | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 7.32M | 44.38% |
| 2026-02-24 | Mr. Jonathan M. N. RigbyPresident, CEO & Director | 3.80M | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 19.98M | 23.48% |
| 2026-02-24 | Dr. Bernd MuehlenwegIndependent Director | 337.47k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.30M | 35.00% |
| 2026-02-24 | Dr. Pericles CaliasChief Development Officer and Head of R&D | 600.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.60M | 60.00% |
| 2026-02-24 | Dr. Stephen SanghaIndependent Director | 880.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 2.28M | 62.85% |
| 2026-02-24 | Mr. David PatersonIndependent Director | 377.97k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.28M | 41.97% |
| 2026-02-24 | Ms. Tanya N. LewisIndependent Director & Observer | 323.97k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.13M | 40.03% |
| 2026-02-24 | Dr. Stephen SanghaIndependent Director | 269.98k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.40M | 23.89% |
| 2025-08-14 | Ms. Tanya N. LewisIndependent Director & Observer | 389.32k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 809.32k | 92.70% |
| 2025-08-14 | Dr. Bernd MuehlenwegIndependent Director | 404.19k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 964.19k | 72.18% |
| 2025-08-14 | Dr. Stephen SanghaIndependent Director | 420.26k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.13M | 59.19% |
| 2025-08-14 | Mr. David PatersonIndependent Director | 410.53k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 900.53k | 83.78% |
| 2025-08-01 | Mr. Jeffrey A. Bachaインサイダー | -5.00k | 724.68 | 売り | 0.14 | 325.00k | -1.52% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
